clinical-stage

Relay Therapeutics is a Cambridge, Massachusetts clinical-stage precision medicines company (NASDAQ: RLAY) using protein motion to drug historically intractable oncology and genetic-disease targets.

Carrick Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Carrick Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, developing novel oncology therapies aimed at improving outcomes for patients with aggressive and treatment-resistant cancers.

Pathios Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Pathios Therapeutics is a clinical-stage oncology and immunology drug discovery and development company based in Oxfordshire, United Kingdom, founded in 2017. The company develops small-molecule inhibitors of the pH-sensing G protein-coupled receptor

Engrail — independent third-party profile of a public API surface, by API Evangelist. Engrail Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 and focused on precision neuroscience. The company develops innovative, precision-targeted small-molecule therapeutics aimed at the molecular mechanisms and neural circuits underlyi

Semnur Pharmaceuticals — independent third-party profile of a public API surface, by API Evangelist. Semnur Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing non-opioid pain-management therapies. Its lead program, SP-102 (SEMDEXA), is a novel, non-opioid, preservative-free and particulate-free injectable corticosteroid

Solu Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Solu Therapeutics is a clinical-stage biotechnology company headquartered in Boston, Massachusetts, pioneering a novel class of antibody therapeutics that unlock cell-surface targets by combining small molecules with effector antibodies through proprieta

Alpha-9 Oncology — independent third-party profile of a public API surface, by API Evangelist. Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that spun out of the University of British Columbia and BC Cancer in 2019 to develop a portfolio of targeted cancer therapies.

Braveheart Bio — independent third-party profile of a public API surface, by API Evangelist. Braveheart Bio is a late clinical-stage biopharmaceutical company developing novel therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiac conditions. Its lead candidate, BHB-1893, is a selective cardiac myosin inhibitor (licensed as HRS-1893

Rallybio — independent third-party profile of a public API surface, by API Evangelist. Rallybio Corporation (NASDAQ RLYB) is a clinical-stage biotechnology company headquartered in New Haven, Connecticut, founded in 2018, developing and commercializing life-transforming therapies for patients with severe and rare diseases.

Chimerix — independent third-party profile of a public API surface, by API Evangelist. Chimerix, Inc. was a biopharmaceutical company headquartered in Durham, North Carolina, focused on developing medicines for serious and life-threatening diseases. It is best known for brincidofovir (TEMBEXA), an antiviral approved by the U.S.

MBX Biosciences — independent third-party profile of a public API surface, by API Evangelist. MBX Biosciences is a clinical-stage biopharmaceutical company developing novel precision peptide therapies for endocrine and metabolic disorders, built on its proprietary PEPs platform. Lead programs include canvuparatide (MBX 2109) for hypoparathyroidism,

Affinia Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Affinia Therapeutics is a clinical-stage biotechnology company in Waltham, Massachusetts pioneering next-generation adeno-associated virus (AAV) gene therapies. Using AI and structural modeling to rationally design novel capsids that better target tis

Escient Pharmaceuticals — independent third-party profile of a public API surface, by API Evangelist. Escient Pharmaceuticals is a San Diego, California clinical-stage biopharmaceutical company developing first-in-class, oral small-molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs) along the neurosensory-inflammatory a

Trishula Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Trishula Therapeutics is a privately held, clinical-stage immuno-oncology company developing cancer immunotherapies that target immune-evasion mechanisms in the tumor microenvironment.

Basking Biosciences — independent third-party profile of a public API surface, by API Evangelist. Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots.

Zenasbio — independent third-party profile of a public API surface, by API Evangelist. Zenas BioPharma is a global clinical-stage biopharmaceutical company focused on developing and delivering transformative treatments for patients with autoimmune and rare diseases. Its lead candidates are obexelimab, a bifunctional monoclonal antibody that inhibit

HilleVax — independent third-party profile of a public API surface, by API Evangelist. HilleVax was a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, most notably HIL-214, a virus-like-particle based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norovirus

Areteia Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Areteia Therapeutics was a clinical-stage biotechnology company, formerly based in Chapel Hill, North Carolina, operating in the life-sciences sector. As of the July 2026 enrichment pass the company is no longer operating: areteiatx.com serves only a

Tenaya Therapeutics * — independent third-party profile of a public API surface, by API Evangelist. Tenaya Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering, designing, developing, and delivering potentially curative gene therapies and precision medicines that address the

Compass Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics for the treatment of cancer. Its research is grounded in understanding the tumor microenvironment, designing candidates that optimize